New York Life Investment Management LLC Has $1.59 Million Stake in DaVita Inc. (NYSE:DVA)

New York Life Investment Management LLC trimmed its stake in shares of DaVita Inc. (NYSE:DVA) by 13.6% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 10,637 shares of the company’s stock after selling 1,669 shares during the period. New York Life Investment Management LLC’s holdings in DaVita were worth $1,591,000 at the end of the most recent reporting period.

Several other large investors have also bought and sold shares of DVA. Wealth Enhancement Advisory Services LLC lifted its holdings in DaVita by 8.4% in the third quarter. Wealth Enhancement Advisory Services LLC now owns 3,482 shares of the company’s stock valued at $571,000 after buying an additional 269 shares during the period. First Trust Direct Indexing L.P. lifted its holdings in DaVita by 2.9% in the third quarter. First Trust Direct Indexing L.P. now owns 3,051 shares of the company’s stock valued at $500,000 after buying an additional 86 shares during the period. Janney Montgomery Scott LLC lifted its holdings in DaVita by 16.4% in the third quarter. Janney Montgomery Scott LLC now owns 24,591 shares of the company’s stock valued at $4,031,000 after buying an additional 3,468 shares during the period. Forum Financial Management LP acquired a new position in DaVita in the third quarter valued at approximately $221,000. Finally, Asset Management One Co. Ltd. raised its holdings in DaVita by 4.7% in the third quarter. Asset Management One Co. Ltd. now owns 19,629 shares of the company’s stock worth $3,218,000 after purchasing an additional 886 shares during the period. 90.12% of the stock is currently owned by institutional investors and hedge funds.

DaVita Stock Down 3.4 %

Shares of DVA stock opened at $142.82 on Tuesday. The firm has a fifty day moving average of $160.45 and a 200-day moving average of $158.18. The company has a quick ratio of 1.21, a current ratio of 1.26 and a debt-to-equity ratio of 23.18. DaVita Inc. has a 12-month low of $124.78 and a 12-month high of $179.60. The company has a market capitalization of $11.43 billion, a price-to-earnings ratio of 13.30, a P/E/G ratio of 1.07 and a beta of 0.94.

DaVita (NYSE:DVA) last issued its quarterly earnings data on Thursday, February 13th. The company reported $2.24 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.14 by $0.10. DaVita had a net margin of 7.31% and a return on equity of 115.48%. As a group, equities research analysts predict that DaVita Inc. will post 10.76 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities research analysts have weighed in on DVA shares. Sanford C. Bernstein set a $184.00 target price on shares of DaVita in a report on Friday, February 21st. Cowen reiterated a “hold” rating on shares of DaVita in a report on Tuesday, February 18th. Finally, Barclays increased their target price on shares of DaVita from $164.00 to $169.00 and gave the stock an “equal weight” rating in a report on Tuesday, February 18th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and two have given a buy rating to the company. According to MarketBeat.com, DaVita presently has a consensus rating of “Hold” and a consensus target price of $166.33.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.